The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the same family as the Ebola virus ...

The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...

Ebola virus disease is a rare but often deadly condition that causes fever, body aches, diarrhea, and sometimes bleeding inside and outside the body. It's caused by viruses commonly called Ebola ...

The filoviruses Ebola and Marburg use several different and effective mechanisms to both evade and battle the immune system. This Review explores recent findings in the filovirus–host-defence ...

The Ebola vaccine rVSV-ZEBOV was approved by the FDA in 2019 but only protects against Zaire ebolavirus, or Ebola virus proper, not any of the other three human-contracted Ebola-causing viruses.

Gilead, the drug's maker, is now testing Obeldesivir in Phase 2 trials for the Marburg virus, a close relative of Ebola.

Ebola is a terrifying virus which, if left untreated, causes bleeding inside the body and through the eyes, nose, mouth and rectum. Case fatality rates have varied from 25% to 90% in past ...

As an outbreak of Ebola swept through central Uganda in late September, government officials were willing to do anything to contain the virus except take one crucial step: impose a lockdown.